Antihypertensive medication adherence and blood pressure control among central Alabama veterans

Journal of Clinical Hypertension

Volumn 19, Issue 5, 2017, Pages 543-549

  Piercefield, Emily W ^a,b   Howard, Molly E ^c   Robinson, Michael H ^c   Kirk, Cain Eric ^c   Ragan, Addison P ^c   Reese, Sondra D ^a  

^a ALABAMA DEPARTMENT OF PUBLIC HEALTH   (United States)

^b NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; THIAZIDE DIURETIC AGENT;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MEDICATION COMPLIANCE; MIDDLE AGED; PATIENT COMPLIANCE; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; TREATMENT REFUSAL; UNITED STATES; ALABAMA; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; DEVICES; DRUG EFFECTS; FEMALE; MALE; STATISTICS AND NUMERICAL DATA; VERY ELDERLY; VETERAN;

ADULT; AGED; AGED, 80 AND OVER; ALABAMA; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; FEMALE; HUMANS; HYPERTENSION; MALE; MEDICATION ADHERENCE; MIDDLE AGED; VETERANS;

EID: 85006466714     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/jch.12953     Document Type: Article

References (34)

1. Ho MP, Bryson CL, Rumsfeld JS. Medication adherence: its importance in cardiovascular outcomes. Circulation. 2009;119:3028–3035.
2. DiMatteo MR1, Giordani PJ, Lepper HS, Croghan TW. Patient adherence and medical treatment outcomes: a meta-analysis. Med Care 2002;40:794–811.
3. Simpson SH, Eurich DT, Majumdar SR, et al. A meta-analysis of the association between adherence to drug therapy and mortality. BMJ. 2006;333:15.
4. Nasseh K, Frazee SG, Visaria J, Vlahiotis A, Tian Y. Cost of medication nonadherence associated with diabetes, hypertension, and dyslipidemia. Am J Pharm Benefits. 2012;4:e41–e47.
5. Roebuck MC1, Liberman JN, Gemmill-Toyama M, Brennan TA. Medication adherence leads to lower health care use and costs despite increased drug spending. Health Aff 2011;30:91–99.
6. Sokol MC, McGuidan KA, Verbrugge RR, Epstein RS. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care. 2005;43:521–530.
7. Haynes RB, McDonald HP, Garg AX. Helping patients follow prescribed treatment: clinical applications. JAMA. 2002;288:2880–2883.
8. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353:487–497.
9. Gu Q, Burt VL, Dillon CF, Yoon S. Trends in antihypertensive medication use and blood pressure control among United States adults with hypertension: the National Health and Nutrition Examination Survey, 2001 to 2010. Circulation. 2012;126:2105–2114.
10. Chobanian AV. Control of hypertension—an important national priority. N Engl J Med. 2001;345:534–535.
11. Institute of Medicine (US) Committee on Public Health Priorities to Reduce and Control Hypertension. A Population-Based Policy and Systems Change Approach to Prevent and Control Hypertension. Washington, DC: National Academies Press; 2010.
12. Shea S, Misra D, Ehrlich MH, Field L, Francis CK. Predisposing factors for severe, uncontrolled hypertension in an inner-city minority population. N Engl J Med. 1992;327:776–781.
13. Nau DP. Proportion of days covered as a preferred method of measuring medication adherence. Pharmacy Quality Alliance http://www.pqaalliance.org/images/uploads/files/PQA%20PDC%20vs%20%20MPR.pdf. Accessed May 31, 2016.
14. Bramley TJ, Gerbino PP, Nightengale BS, Frech-Tamas F. Relationship of blood pressure control to adherence with antihypertensive monotherapy in 13 managed care organizations. J Manag Care Pharm. 2006;12:239–245.
15. Kjeldsen S, Feldman RD, Lisheng L, et al. Updated national and international hypertension guidelines: a review of current recommendations. Drugs. 2014;74:2033–2051.
16. Schroeder K, Fahey T, Ebrahim S. How can we improve adherence to blood pressure-lowering medication in ambulatory care? Systematic review of randomized controlled trials. Arch Intern Med. 2004;164:722–732.
17. Viswanathan M, Golin CE, Jones CD, et al. Interventions to improve adherence to self-administered medications for chronic diseases in the United States: a systematic review. Ann Intern Med. 2012;157:785–795.
18. Go AS, Bauman MA, Coleman King SM, et al. An effective approach to high blood pressure control: a science advisory from the American Heart Association, the American College of Cardiology, and the Centers for Disease Control and Prevention. J Am Coll Cardiol. 2014;63:1230–1238.
19. Jaffe MG, Lee GA, Young JD, Sidney S, Go AS. Improved blood pressure control associated with a large-scale hypertension program. JAMA. 2013;310:699–705.
20. Community Preventive Services Task Force. Team-based care to improve blood pressure control: recommendation of the Community Preventive Services Task Force. Am J Prev Med. 2014;47:100–102.
21. Cutrona SL, Choudhry NK, Fischer MA, et al. Modes of delivery for interventions to improve cardiovascular medication adherence: a systematic review. Am J Manag Care. 2010;16:929–942.
22. Hirsch JD, Steers N, Adler DS, et al. Primary care-based, pharmacist-physician collaborative medication-therapy management of hypertension: a randomized, pragmatic trial. Clin Ther. 2014;36:1244–1254.
23. Walsh J, McDonald K, Shojania K, et al. Quality improvement strategies for hypertension management: a systematic review. Med Care. 2006;44:646–657.
24. Bosworth HB, Powers BJ, Olsen MK, et al. Home blood pressure management and improved blood pressure control: results from a randomized controlled trial. Arch Intern Med. 2011;171:1173–1180.
25. Mason JM, Freemantle N, Gibson JM, New JP. Specialist nurse-led clinics to improve control of hypertension and hyperlipidemia in diabetes: economic analysis of the SPLINT trial. Diabetes Care. 2005;28:40–46.
26. Rudd P, Miller NH, Kaufman J, et al. Nurse management for hypertension: a systems approach. Am J Hypertens. 2004;17:921–927.
27. Viswanathan M, Golin CE, Jones CD, et al. Medication adherence interventions: comparative effectiveness. Closing the quality gap: revisiting the state of the science. Evidence Report No. 208. (Prepared by RTI International–University of North Carolina Evidence-based Practice Center under Contract No. 290-2007-10056-I.) AHRQ Publication No. 12-E010-EF. Agency for Healthcare Research and Quality, Rockville, MD, September 2012. https://www.effectivehealthcare.ahrq.gov/ehc/products/296/1249/EvidenceReport208_CQGMedAdherence_ExecutiveSummary_20120904.pdf. Accessed May 31, 2016.
28. Carter BL, Zillich AJ, Elliott WJ. How pharmacists can assist physicians with controlling blood pressure. J Clin Hypertens (Greenwich). 2003;5:31–37.
29. Lee JK, Grace KA, Taylor AJ. Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized controlled trial. JAMA. 2006;296:2563–2571.
30. Morgado M, Rolo S, Castelo-Branco M. Pharmacist intervention program to enhance hypertension control: a randomised controlled trial. Int J Clin Pharm. 2011;33:132–140.
31. Proia KK, Thota AB, Njie GJ, et al. Team-based care and improved blood pressure control: A Community Guide systematic review. Am J Prev Med. 2014;47:86–99.
32. Jacob V, Chattopadhyay SK, Thota AB, et al. Community Preventive Services Task Force. Economics of team-based care in controlling blood pressure: a Community Guide systematic review. Am J Prev Med. 2015;49:772–783.
33. Steiner JF, Prochazka AV. The assessment of refill compliance using pharmacy records: methods, validity, and applications. J Clin Epidemiol. 1997;50:105–116.
34. Steiner JF, Ho PM, Beaty BL, et al. Sociodemogrphic and clinical characteristics are not clinically useful predictors of refill adherence in patients with hypertension. Cir Cardiovasc Qual Outcomes. 2009;2:451–457.